Human Genome Sciences (United States)

Institution (Company)

Homepage Wikipedia ROR

Also Known As

Human Genome Sciences (United States)

1.5K

Publications

732.5K

Citations

286

Authors

606

Concepts

About

Human Genome Sciences (United States) is a company institution in Rockville, United States known for medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	26	121	22.9K
2	Health Sciences	21	79	6.4K
3	Law	2	2	48
4	Education	1	5	75
5	Language Studies	1	1	30

Human Genome Sciences (United States)

1.5K

Publications

732.5K

Citations

Page 1

	Year	Citations
De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis Brian J. Haas, Alexie Papanicolaou, Moran Yassour, Nature Protocols Functional GenomicsMedicineGeneticsNatural SciencesSequence Analysis	2013	8.7K
Genetic effects on gene expression across human tissues Nature GeneticsGenomicsGene Expression ProfilingGenome-wide Association StudyGenetic Analysis	2017	4.5K
Global variation in copy number in the human genome Richard Redon, Shumpei Ishikawa, Karen Fitch, Nature MedicineGeneticsGenome AnalysisGenetic VariationGenomics	2006	4.3K
The complete genome sequence of the gastric pathogen Helicobacter pylori Jean-F. Tomb, Owen White, Anthony R. Kerlavage, Nature GeneticsSequence AnalysisGenome SequencingMicrobiologyGenomics	1997	3.5K
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex Marta Muzio, Arul M. Chinnaiyan, Frank Kischkel, Cell Death-inducing Signaling ComplexSignal TransductionSignaling PathwayProtein FunctionMedicine	1996	3K
Comprehensive molecular characterization of urothelial bladder carcinoma John N. Weinstein, Gordon Saksena Nature	2014	3K
Targeted capture and massively parallel sequencing of 12 human exomes Sarah Ng, Emily H. Turner, Peggy D. Robertson, Nature BioinformaticsLong-read SequencingDna SequencingParallel SequencingNext-generation Sequencing	2009	2K
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial Sandra Navarra, Renato Guzmán, A Gallacher, The Lancet RheumatologyAutoimmune DiseaseLupusSystemic TreatmentLupus Nephritis	2011	2K
The Receptor for the Cytotoxic Ligand TRAIL Guohua Pan, Karen O’Rourke, Arul M. Chinnaiyan, Science	1997	1.8K
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus Richard Furie, Michelle Petri, Omid Zamani, Arthritis & Rheumatism	2011	1.6K

Page 1